Founded in 2013Cambridge, Massachusetts, United States500-1000 employees$150 M
Healthcare
111 ratings
0 ratings
Highlights
nFerence Labs also called the "Google of Biomedicine", is building the world's first massive-scale platform for pharmaco-biomedical computing.
Our platform is premised on using AI/Deep Learning (on clinical text, medical images, and other signals) and massive high-performance computing to help pharma companies perform faster and more efficient drug discovery and help early diagnosis of several key diseases.
Total Funding
$150 M
Latest Funding
$60 M
Series C • Jan 2021
Founders
Venky Soundararajan
Founder & Chief Scientific Officer
B.Tech. from IIT Guwahati, PhD from Massachusetts Institute of Technology, Research Fellowship from Harvard Medical School
Entrepreneur, scientist and inventor. Dr. Soundararajan has led multi- year R&D data-science collaborations with some of the world’s largest enterprises.
Qrativ acquired by nFerence
Murali Aravamudan
Founder and CEO
Indian Institute of Science (IISc)
ex-Veveoex-Winphoria Networks
Serial entrepreneur, inventor and engineer who has built, led and exited several successful media and telecom technology companies prior to founding nference
Rovi acquired by Veveo
Investors
Matrix Partners
Also Investor At:
Quora ,
Canva ,
Hubspot
Matrix Capital Management
Also Investor At:
Salesforce ,
Qualcomm Inc ,
Netflix
Mayo Clinic Ventures
Also Investor At:
Cadence Neuroscience ,
Nuvolo ,
Turtle Health
NTT Venture Capital
Also Investor At:
Eko ,
Celona ,
Zoba
About
The exponential growth of biomedical data, driven by the adoption of electronic medical records (EMRs), provides an unprecedented opportunity to create transformative technologies and products in healthcare.
nference partners with medical centers to turn decades of rich and predominantly unstructured data captured in EMRs into powerful solutions that enable scientists to discover and develop the next-generation of personalized diagnostics and treatments for patients worldwide. We believe that the greatest opportunity for our generation to elevate human health is by developing technology to curate and synthesize the world’s biomedical data in order to enable that scientific discovery.
Staff Software Engineer· Posted more than a month ago
Full-Time · Bengaluru · 40-53L
Not able to find the Job you are looking for?
Upload your resume and we will notify you as they are posted
Companies in same Industries / Domain
Carestack
Healthcare
Dozee
Healthcare, Artificial Intelligence, IoT
Fitterfly
Healthcare and Wellness
NirogStreet
Healthcare
$12M •
Live Your Best Life
Healthcare
111 ratings
0 ratings
Highlights
nFerence Labs also called the "Google of Biomedicine", is building the world's first massive-scale platform for pharmaco-biomedical computing.
Our platform is premised on using AI/Deep Learning (on clinical text, medical images, and other signals) and massive high-performance computing to help pharma companies perform faster and more efficient drug discovery and help early diagnosis of several key diseases.
Total Funding
$150 M
Latest Funding
$60 M
Series C • Jan 2021
Founders
Venky Soundararajan
Founder & Chief Scientific Officer
B.Tech. from IIT Guwahati, PhD from Massachusetts Institute of Technology, Research Fellowship from Harvard Medical School
Entrepreneur, scientist and inventor. Dr. Soundararajan has led multi- year R&D data-science collaborations with some of the world’s largest enterprises.
Qrativ acquired by nFerence
Murali Aravamudan
Founder and CEO
Indian Institute of Science (IISc)
ex-Veveoex-Winphoria Networks
Serial entrepreneur, inventor and engineer who has built, led and exited several successful media and telecom technology companies prior to founding nference
Rovi acquired by Veveo
Investors
Matrix Partners
Also Investor At:
Quora ,
Canva ,
Hubspot
Matrix Capital Management
Also Investor At:
Salesforce ,
Qualcomm Inc ,
Netflix
Mayo Clinic Ventures
Also Investor At:
Cadence Neuroscience ,
Nuvolo ,
Turtle Health
NTT Venture Capital
Also Investor At:
Eko ,
Celona ,
Zoba
About
The exponential growth of biomedical data, driven by the adoption of electronic medical records (EMRs), provides an unprecedented opportunity to create transformative technologies and products in healthcare.
nference partners with medical centers to turn decades of rich and predominantly unstructured data captured in EMRs into powerful solutions that enable scientists to discover and develop the next-generation of personalized diagnostics and treatments for patients worldwide. We believe that the greatest opportunity for our generation to elevate human health is by developing technology to curate and synthesize the world’s biomedical data in order to enable that scientific discovery.